SCHEMBL9853199

SCHEMBL9853199

CC(=O)NCCOC(=O)CC(=O)OCCNC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.50
MTNR1B P49286 4/20 0.50
MAPK1 P28482 2/20 0.48
KDM4E B2RXH2 2/20 0.48
HIF1A Q16665 1/20 0.48
TSHR P16473 2/20 0.46
USP2 O75604 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
PAOX Q6QHF9 3/20 0.40
ADRA1A P35348 1/20 0.39
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20954435 0.91 MTNR1A (0.47) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL11923029 0.86 MTNR1A (0.47) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL8054587 0.85 MTNR1A (0.46) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL279485 0.83 MAPK1 (0.50) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL5511272 0.81 MTNR1A (0.43) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL685408 0.80 THRB (0.52) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL14389742 0.80 MTNR1A (0.44) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL15604382 0.80 MTNR1A (0.42) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL10580277 0.79 MAPK1 (0.46) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL16677194 0.79 MAPK1 (0.46) MTNR1AMTNR1BMAPK1KDM4EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101253164-B Indole-3-carbonyl-spiro-piperidine derivatives as V1a receptor antagonists HOFFMANN LA ROCHE 2012-05-16 CN disclosed
EP-0413293-A2 1-(Benzo[b]thienyl)-2-(thienyl) ethenes and related compounds, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-02-20 EP disclosed
US-4904674-A FREE OF AGGLOMERATION OF FIBRILLATION HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1990-02-27 US disclosed